Clinical characterisation and outcomes of human clade IIb mpox virus disease - a European multicentre observational cohort study (MOSAIC).
AuteursPesonel E, Laouénan C, Guiraud L, Bourner J, Hoffmann I, Molino D, Tardivon C, Bachelet D, Mentré F, Amstutz A, Merson L, Rojek A, Cervantes Gonzalez M, Antinori A, Castagna A, Nozza S, Pourcher V, Libois A, Dunning J, Tacconelli E, Hites M, De La Calle Prieto F, Horby P, Yazdanpanah Y, Calmy A, Lescure FX, Olliaro P
Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109).
AuteursAgostinetto E, Pfeiler G, Hlauschek D, Mayer EL, Lambertini M, de Azambuja E, Bellet-Ezquerra M, Meisel JL, Rubovszky G, Zdenkowski N, Novik Y, Ruiz-Borrego M, Gelmon KA, Mamounas EP, Iwata H, Lu DR, Soelkner L, Fesl C, Gnant M, DeMichele A
[Retracted] Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles.
AuteursAftimos PG, Wiedig M, Fontsa ML, Awada A, Ghanem G, Journe F